← All diseases

Disease Atlas / Disease detail

Macular Degeneration

This is an educational guide that concisely summarizes the types, symptoms, examinations, management, and interpretation of evidence for macular degeneration.

macular degeneration · macula lutea retinal degeneration · macula retinal degeneration · retinal degeneration of macula lutea

MONDO:0003004Public QA completeSource-bound · 4

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · b635d56eb676

Disease category
Macular degeneration is a category of diseases in which damage to the macula of the eye can lead to a decline in clear central vision, and the provided overview primarily describes age-related macular degeneration (AMD).
Core mechanism
Age-related macular degeneration is influenced by age-related changes, and environmental and lifestyle factors, including genetic predisposition and smoking, may contribute to the risk.
Main causes · related factors
In dry AMD, the light-sensing cells of the macula are gradually damaged, whereas in wet AMD, abnormal blood vessels grow beneath the macula, causing blood and fluid to leak, which can lead to relatively rapid damage.
Representative features
Typical symptoms may include blurred central vision, metamorphopsia (where straight lines appear wavy), and difficulty with fine tasks such as reading and driving, while pain is uncommon.
Individual differences
The risk and pattern of progression may vary by individual depending on age, family history/genetic background, smoking, cardiovascular/metabolic status, and living environment.
Diagnosis
In dry AMD, central vision may gradually decline, whereas in wet AMD, vision changes may be rapid, and in the early stages, the severity may differ between one eye or both eyes.
Management
Diagnosis is made by comprehensively combining medical history and visual acuity assessment with fundus examination, dilated fundus examination, and retinal imaging if necessary.
Treatment/Research Status
Regular comprehensive ophthalmic examinations help detect changes before vision loss becomes prominent, and the type or severity cannot be determined by the disease category name alone.
Read Evidence
Management is planned by confirming the type and degree of progression, then combining monitoring of vision changes, adjustment of risk factors, necessary ophthalmic treatment, and visual rehabilitation.
Key Precautions
Current treatment is generally aimed at slowing the progression of vision loss or reducing damage, and does not always restore vision that has already been lost.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a Glance

Macular degeneration is a category of diseases in which damage to the macula of the eye can lead to a decline in clear central vision, and the provided overview primarily describes age-related macular degeneration (AMD).

Typical symptoms may include blurred central vision, metamorphopsia (where straight lines appear wavy), and difficulty with fine tasks such as reading and driving, while pain is uncommon.

How the disease works

Age-related macular degeneration is influenced by age-related changes, and environmental and lifestyle factors, including genetic predisposition and smoking, may contribute to the risk.

In dry AMD, the light-sensing cells of the macula are gradually damaged, whereas in wet AMD, abnormal blood vessels grow beneath the macula, causing blood and fluid to leak, which can lead to relatively rapid damage.

Variations in presentation among individuals

The risk and pattern of progression may vary by individual depending on age, family history/genetic background, smoking, cardiovascular/metabolic status, and living environment.

The broad framework of diagnosis and management

In dry AMD, central vision may gradually decline, whereas in wet AMD, vision changes may be rapid, and in the early stages, the severity may differ between one eye or both eyes.

Diagnosis is made by comprehensively combining medical history and visual acuity assessment with fundus examination, dilated fundus examination, and retinal imaging if necessary.

Current status of treatment

Regular comprehensive ophthalmic examinations help detect changes before vision loss becomes prominent, and the type or severity cannot be determined by the disease category name alone.

Management is planned by confirming the type and degree of progression, then combining monitoring of vision changes, adjustment of risk factors, necessary ophthalmic treatment, and visual rehabilitation.

Current treatment is generally aimed at slowing the progression of vision loss or reducing damage, and does not always restore vision that has already been lost.

How to read clinical trials

Follow-up is the process of comparing changes in vision and the retina over time, and the mere existence of registered observational studies should not be interpreted as implying treatment efficacy, approval, or standard of care.

Points to verify during clinical consultations

In clinical practice, it is important to check the onset and rate of vision changes, differences between one eye and both eyes, straight-line distortion or central scotoma, medications and smoking, family history, test results, and follow-up plans.

Medical Guidance

This material is for educational purposes and is not intended as a guide for individual diagnosis or treatment. Judgments regarding symptoms or test results and treatment decisions should be made in consultation with ophthalmic medical staff.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.